CN203874107U - Negative pressure type lactic acid levofloxacin sodium chloride injection - Google Patents
Negative pressure type lactic acid levofloxacin sodium chloride injection Download PDFInfo
- Publication number
- CN203874107U CN203874107U CN201420228178.7U CN201420228178U CN203874107U CN 203874107 U CN203874107 U CN 203874107U CN 201420228178 U CN201420228178 U CN 201420228178U CN 203874107 U CN203874107 U CN 203874107U
- Authority
- CN
- China
- Prior art keywords
- bag
- medicine
- cork
- negative pressure
- protective bag
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims abstract description 32
- 239000004310 lactic acid Substances 0.000 title claims abstract description 16
- 235000014655 lactic acid Nutrition 0.000 title claims abstract description 16
- NCGMIBYQHQSCGQ-PPHPATTJSA-M levofloxacin sodium Chemical compound [Na+].C([C@@H](N1C2=C(C(C(C([O-])=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 NCGMIBYQHQSCGQ-PPHPATTJSA-M 0.000 title claims abstract description 16
- 239000008354 sodium chloride injection Substances 0.000 title claims abstract description 13
- 230000001681 protective effect Effects 0.000 claims abstract description 28
- 238000007789 sealing Methods 0.000 claims abstract description 11
- 229910000679 solder Inorganic materials 0.000 claims abstract description 10
- 238000001802 infusion Methods 0.000 claims description 26
- 239000007799 cork Substances 0.000 claims description 25
- 238000009434 installation Methods 0.000 claims description 6
- 239000011888 foil Substances 0.000 claims description 4
- 238000010030 laminating Methods 0.000 claims description 3
- 238000003466 welding Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 17
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 7
- 238000000034 method Methods 0.000 abstract description 6
- 230000008569 process Effects 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 238000005476 soldering Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 description 7
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000012856 packing Methods 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Inorganic materials [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical group FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 229960001699 ofloxacin Drugs 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 108010054814 DNA Gyrase Proteins 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 238000009455 aseptic packaging Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Packages (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
The utility model discloses a negative pressure type lactic acid levofloxacin sodium chloride injection. The inner surface of a protective bag is tightly attached to the outer surface of a medicine package bag, a medicine adding transfusion port is welded to the medicine package bag through a flat solder side, a transverse groove and a boss are arranged on the surface of the solder side, a soft plug expansion buffer chamber is arranged in the medicine adding transfusion port, and a sealing cover is arranged in the mouth of the medicine adding transfusion port. The space between the protective bag and the medicine package bag is of a negative pressure structure, and the inner surface of the protective bag is tightly attached to the outer surface of the medicine package bag; whether the medicine package bag is provided with a tiny hole or not can be observed with eyes; the surface of the solder side is provided with the transverse groove and the boss, so that soldering firmness and leakproofness of the solder side are ensured. As the medicine adding transfusion port is provided with the sealing cover, it is ensured that the medicine adding transfusion port does not make contact with the outside world in the production and carrying processes of a transfusion bag, and no germ is generated. The operations of medicine adding and transfusion can be carried out after the sealing cover is opened, and disinfection is not needed. The soft plug expansion buffer chamber is arranged below a soft plug, so that the soft plug is prevented from generating chips.
Description
Technical field
This utility model relates to a kind of transfusion transfusion bag, is field of medicaments.
Background technology
The levo form that lactic acid levofloxacin sodium chloride this product is ofloxacin, its antibacterial activity is about 2 times of ofloxacin, and its main mechanism is anti-bacteria DNA gyrase activity, anti-bacteria DNA replication dna.There is has a broad antifungal spectrum, feature that antibacterial action is strong.
Manufacture field at medicine, lactic acid levofloxacin sodium chloride is filled in kit pack, then by human vein drip-injection method, input human body, to reach administration, this series products is referred to as lactic acid levofloxacin sodium chloride soft bag infusion by we, or lactic acid levofloxacin sodium chloride injection.
Infusion treatment disease is a kind of therapeutic modality conventional in modern medical service.The mode that the nutrient that needed by human body in therapeutic process is wanted or medicine are directly inputted by intravenous drip, completes human body is carried out to administration, then, by the blood circulation of human body self, medicine or nutrition is delivered to Whole Body.The manner of packing of transfusion, by initial glass bottle packaging, is improved to plastic bottle packing, then by the improvement of technology, has been upgraded to the bag type package of present optimum.Bag type package is disposable use, and it is safe, and in infusion process, not needing to introduce extraneous air increases pressure, can complete transfusion.
Existing bag-type infusion is packed its shortcoming:
1, because of transfusion bag adopt be soft bag type package material, the quality of its material is soft, in the course of processing, may occur that the material processing has micropore phenomenon, or transport, move in process, all likely Drug packing is damaged.These reasons can cause producing in transfusion bag micro-, and these micropores are very tiny, and naked eyes cannot be observed; Medicinal liquid can not exosmose at short notice, or in the process of exosmosing, has produced volatilization, and naked eyes cannot be found.The harm of micropore is, micropore will form a passage outward with bag in transfusion bag, and airborne antibacterial can enter in bag by this passage, and this destroys the medicinal liquid in bag.
2, in use, because safe and sanitary needs, require the infusion port of transfusion bag to carry out disinfection, this can cause some inconvenience to nurse's work, there are on the market now some Easy-folding transfusion lids, the use that in use infusion port front end fractureed, without sterilization, but its production cost of this mode is higher.
3, in liquid feeding infusion port, install and insert the cork that transfusion needle is used, in the time penetrating cork with needle point, by friction, cork can produce bits, falls bits and falls in the medicinal liquid of transfusion bag and infusion bottle, pollutes medicinal liquid.
Utility model content
Negative-pressure type lactic acid levofloxacin sodium chloride injection; comprise protective bag 8 and kit pack; kit pack 7 is inserted in protective bag 8; in kit pack, be welded with medicine-adding infusion mouth 5; between protective bag and kit pack, be negative pressure structure, the intimate laminating of protective bag inner surface and kit pack.Medicine-adding infusion mouth lower end is provided with solder side 6, and medicine-adding infusion mouth is by solder side and kit pack welding; Solder side 6 is flat mouthful, and is provided with transverse concave groove and boss on surface.
Negative-pressure type lactic acid levofloxacin sodium chloride injection as above, further illustrate into, cork installation room and cork expansion buffer chamber 10 are set in medicine-adding infusion mouth, cork 9 is set in cork installation room, cork expansion buffer chamber is arranged on cork installation room below.
On the port of medicine-adding infusion mouth, be provided with sealing cover body 4, described sealing cover body is plastic foil.
Negative-pressure type lactic acid levofloxacin sodium chloride injection as above, further illustrate into, the bag mouth of protective bag is provided with negative pressure extracting mouth 2, in order to will protective bag and kit pack between extract negative pressure.
Protective bag surrounding has edge band 3; The width of its edge band is 3-5mm, and negative pressure extracting mouth 2 places are provided with tears bag breach 1; Described protective bag 8 is transparent PVC bag; Described kit pack 7 is non-PVC bag.
Described cork expansion buffer chamber 10 degree of depth are 2-6mm.
Beneficial effect:
Between protective bag and kit pack, it is negative pressure structure; The intimate laminating of protective bag inner surface and kit pack; There is micropore if there is kit pack, can form water mark in the joint place between protective bag and kit pack, with the naked eye can observe.
The surface of seam face is provided with transverse concave groove and boss, has ensured the firm and airtight of its seam.Owing to having adopted groove and boss structure, after seam, be equivalent to form multi-stage sealed, ensure sealing.
On medicine-adding infusion mouth, be provided with sealing cover body, in the production of transfusion bag, move in process, ensured that medicine-adding infusion mouth does not contact with the external world, do not produce antibacterial, sealing cover body just can dosing and transfusion operation after taking off, need not sterilize.
Negative pressure extracting mouth place is provided with tears a bag breach, easy to use.
Described protective bag is transparent PVC bag, and its material is good, after extraction negative pressure, can keep for a long time the negative pressure pressure in bag.Situation in the convenient observation bag of simultaneously transparent bag.
The below of cork arranges the swollen surge chamber that rises of cork, and in the time penetrating cork with needle point, cork has enough large swollen space of rising downwards, reduces the friction of needle point to cork, prevents that cork from falling bits.Moreover, when cork still falls in the situation of bits, fall bits and can drop in cork surge chamber, reduce the pollution to medicinal liquid.
Brief description of the drawings
Fig. 1 is structure chart of the present utility model.
Fig. 2 is medicine-adding infusion mouth partial sectional view.
Fig. 3 is medicine-adding infusion mouth structure figure.
Detailed description of the invention
This utility model is implemented in the following way:
One, make kit pack 7, and pour into lactic acid levofloxacin sodium chloride injection.
Kit pack 7 is the plastic material matter of non-PVC, and the packaging material of buying, all through aseptic packaging, entering into before workshop, are disinfected.After cutting is folding, with medicine-adding infusion 5 seam.Medicine-adding infusion mouth 5 places have been provided with sealing cover body 4, and have carried out pre-sterilization.
After seam, start to carry out the injection of lactic acid levofloxacin sodium chloride injection.
Two, be inserted in protective bag.
The Drug packing bag that has injected lactic acid levofloxacin sodium chloride injection is encased in protective bag 8.Extract negative pressure simultaneously.Then to the entirety sterilization that carries out disinfection.
Protective bag 8, through seam edge in advance below, while extracting negative pressure, can have enough intensity to bear negative pressure pressure in the later stage.Then cut and tear bag breach 1.
Three, use.
In use, by perusal, can see that whether kit packs perforation.
In the situation that determining this kit pack without leakage, use.When use, tear protective bag along tearing a bag breach, take out kit pack, the plastic foil of opening gently on medicine-adding infusion mouth just can directly use (without sterilization).Extremely facilitate the place such as operating room or salvage at scene of abrasive.
Plastic foil on medicine-adding infusion mouth can use and the transparent PVC of protective bag 8 with material, also can use and the non-PVC of kit pack with material.
Claims (3)
1. negative-pressure type lactic acid levofloxacin sodium chloride injection; comprise protective bag (8) and kit pack (7), kit pack (7) is inserted in protective bag (8), in kit pack, is welded with medicine-adding infusion mouth (5); between protective bag and kit pack, be negative pressure structure, it is characterized in that:
The intimate laminating of protective bag inner surface and kit pack;
Medicine-adding infusion mouth lower end is provided with solder side (6), and medicine-adding infusion mouth is by solder side and kit pack welding; Solder side (6) is flat mouthful, and is provided with transverse concave groove and boss on surface;
Cork installation room and cork expansion buffer chamber (10) are set in medicine-adding infusion mouth, cork (9) is set in cork installation room, cork expansion buffer chamber is arranged on cork installation room below;
On the port of medicine-adding infusion mouth, be provided with sealing cover body (4), described sealing cover body is plastic foil.
2. negative-pressure type lactic acid levofloxacin sodium chloride injection as claimed in claim 1, is characterized in that, the bag mouth of protective bag is provided with negative pressure extracting mouth (2), in order to extracting negative pressure between protective bag and kit pack;
Protective bag surrounding has edge band (3); The width of its edge band is 3-5mm, and negative pressure extracting mouth (2) is located to be provided with and torn a bag breach (1); Described protective bag (8) is transparent PVC bag; Described kit pack (7) is non-PVC bag.
3. negative-pressure type lactic acid levofloxacin sodium chloride injection as claimed in claim 1, is characterized in that, described cork expansion buffer chamber (10) degree of depth is 2-6mm.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201420228178.7U CN203874107U (en) | 2014-05-07 | 2014-05-07 | Negative pressure type lactic acid levofloxacin sodium chloride injection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201420228178.7U CN203874107U (en) | 2014-05-07 | 2014-05-07 | Negative pressure type lactic acid levofloxacin sodium chloride injection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN203874107U true CN203874107U (en) | 2014-10-15 |
Family
ID=51674663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201420228178.7U Expired - Lifetime CN203874107U (en) | 2014-05-07 | 2014-05-07 | Negative pressure type lactic acid levofloxacin sodium chloride injection |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN203874107U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108452398A (en) * | 2018-05-14 | 2018-08-28 | 镇江高冠医疗器械有限公司 | A kind of non-electric drive portable infusion device |
-
2014
- 2014-05-07 CN CN201420228178.7U patent/CN203874107U/en not_active Expired - Lifetime
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108452398A (en) * | 2018-05-14 | 2018-08-28 | 镇江高冠医疗器械有限公司 | A kind of non-electric drive portable infusion device |
| CN108452398B (en) * | 2018-05-14 | 2023-12-15 | 江苏诚益达智能科技有限公司 | Non-electric drive portable infusion device |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN203694254U (en) | Bottle stopper puncture device | |
| JP2019181181A (en) | Sterile flexible package with pressure compensator for dosed reconstitution of fluid medicinal or nutritional substances to be administered to patients by infusion or injection | |
| CN204050323U (en) | Vacuum type double-layer sterile bivalve layer co-extrusion film infusion bag | |
| CN203874107U (en) | Negative pressure type lactic acid levofloxacin sodium chloride injection | |
| CN103316388B (en) | The integrated infusion container be communicated with by puncture | |
| CN203874103U (en) | Negative pressure type transfusion bag | |
| CN203874106U (en) | Vacuum multilayer co-extrusion film infusion bag | |
| CN203874109U (en) | Negative pressure type polypropylene blending transfusion bag | |
| CN203874110U (en) | Negative pressure type internally sealed polypropylene transfusion bag | |
| CN203874102U (en) | Negative pressure type multi-layer coextruded film transfusion bag | |
| CN203874105U (en) | Negative pressure type internally sealed polyethylene transfusion bag | |
| CN203874111U (en) | Vacuum type infusion bag | |
| CN203874108U (en) | Negative pressure type sophocarpidine sodium chloride injection | |
| CN203989030U (en) | Negative-pressure type glycerin and fructose injection | |
| CN204050325U (en) | Double casing sterilizing transfusion flexible bag | |
| CN203989029U (en) | Negative-pressure type fluconazol sodium chloride injection | |
| CN203874101U (en) | Vacuum inner-sealing type polyethylene infusion bag | |
| CN203874104U (en) | Vacuum type polypropylene blend infusion bag | |
| CN203874112U (en) | Vacuum inner-sealing type polypropylene infusion bag | |
| CN204050322U (en) | Negative-pressure type Ribavirin Glucose Injection | |
| CN203915475U (en) | Negative-pressure type leakproof sterile bivalve layer co-extrusion film infusion bag | |
| CN203970904U (en) | Vacuum type leakproof sterile bivalve layer co-extrusion film infusion bag | |
| CN203915478U (en) | Negative-pressure type double-layer sterile bivalve layer co-extrusion film infusion bag | |
| CN204050324U (en) | Vacuum type bivalve layer co-extrusion film infusion bag | |
| CN203989028U (en) | Negative-pressure type compound formula mannitol injection liquid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20141015 |